Candel Therapeutics amends open market sale agreement, increases offering capacity to $50M

Candel Therapeutics entered into a Second Amended and Restated Open Market Sale Agreement with Jefferies LLC, expanding the share sale program with a total capacity of up to $50,000,000. This amendment increases the capital-raising authority for the biotech company.